Steris (STE) Income towards Parent Company (2018 - 2025)
Steris' (STE) quarterly Income towards Parent Company came in at -$800000.0 in Q1 2025, up 99.48% year-on-year from -$401039.6 in Q1 2024, and down 700.0% quarter-over-quarter from -$100000.0 in Q4 2024.
Steris (STE) Income towards Parent Company (2018 - 2025) Analysis & Trends
Steris' Income towards Parent Company history runs 8 years deep, the most recent figure standing at -$800000.0 for Q1 2025.
- On a quarterly basis, Income towards Parent Company rose 99.48% year-over-year to -$800000.0 in Q1 2025; TTM through Dec 2025 was -$800000.0, a 99.46% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 102.6% from the prior year.
- Income towards Parent Company fell to -$800000.0 in Q1 2025 per STE's latest filing, from -$100000.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at $143.1 million in Q4 2021 and bottomed at -$439.1 million in Q3 2022.
- The 5-year median for Income towards Parent Company is -$800000.0 (2025), against an average of -$14.6 million.
- Biggest YoY gain for Income towards Parent Company was 182.46% in 2024; the steepest drop was 3338.22% in 2024.
- Year by year, Income towards Parent Company stood at $143.1 million in 2021, then slumped by 105.37% to -$7.7 million in 2022, then increased by 0.29% to -$7.7 million in 2023, then soared by 98.69% to -$100000.0 in 2024, then slumped by 700.0% to -$800000.0 in 2025.
- Per Business Quant, the three latest STE Income towards Parent Company figures stand at -$800000.0 (Q1 2025), -$100000.0 (Q4 2024), and -$200000.0 (Q3 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Steris | 21.55 Bn | 21.11 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -800,000.00 |
| Dec 31, 2024 | -100,000.00 |
| Sep 30, 2024 | -200,000.00 |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | -154.30 Mn |
| Dec 31, 2023 | -7.66 Mn |
| Sep 30, 2023 | -4.45 Mn |
| Jun 30, 2023 | -6.79 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | -7.68 Mn |
| Sep 30, 2022 | -439.14 Mn |
| Jun 30, 2022 | -8.33 Mn |
| Mar 31, 2022 | 93.64 Mn |
| Dec 31, 2021 | 143.09 Mn |
| Sep 30, 2021 | 69.63 Mn |
| Jun 30, 2021 | -21.90 Mn |
| Mar 31, 2021 | 86.74 Mn |
| Dec 31, 2020 | 114.59 Mn |
| Sep 30, 2020 | 106.01 Mn |
| Jun 30, 2020 | 89.53 Mn |